Market Research Reports, Inc. (www.marketresearchreports.com): MarketResearchReports.com: Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020, Revels New Report
(M2 PressWIRE Via Acquire Media NewsEdge) The global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery & development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.
The complete report is available @ http://www.marketresearchreports.com/allied-market-research/biomarkers-market-diagnostic-applications-risk-assessment-molecular
"Diagnostic biomarkers continue to address challenges such as early and accurate diagnosis of most of the fatal diseases. Increasing advancements with extended applications of diagnostic biomarkers are only going to increase its significance in the field of diagnostics" according to AMR analysts Debbie Shields and Roshan Deshmukh. "Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic" add the analysts.
Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to genomic pattern of an individual which needs to be extremely confidential.
Read all Medical Diagnostics Reports at http://www.marketresearchreports.com/diagnostics
This report segments the global diagnostic biomarker on the basis of diagnostic biomarker types, applications and service. Applications market further segments as risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications and others. The report particularly focuses on biomarkers for diagnostic applications and excludes clinical trials and research.
With respect to geography, Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020. Companies profiled in this report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthcare Inc. (U.K).
Read all Biotechnology Reports at http://www.marketresearchreports.com/biotechnology
Key benefits of report -
- Assessment and ranking the factors that favour the market growth and those factors which act as a hindrance for the growth of the market
- The market sizing and estimation period is from 2013 to 2020. Two historic years include 2011 and 2012
- The report identifies and analyses top investment pockets and top winning strategies for diagnostic biomarker market
- The report analyses the various strategies adopted by some of the key companies in the market
- The report tracks and analyses key innovations and patents for biomarkers in the last five years
Spanning over 151 pages, 53 tables and 47 figures, "Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intel" report covering Introduction, Executive Summary, Market Overview, Global Diagnostic Biomarker Market by Types, Global Diagnostic Biomarker Market by Applications, Global Diagnostic Biomarker Market by Services, Global Diagnostic Biomarker Market by Geography, Competitive Landscape, Company Profile. This report covers 10 companies - Abbott Laboratories, Inc., Agilent Technologies Inc., Aushon Biosystem, Bio-Rad Laboratories, Eisai Co. Ltd., Epistem Ltd., GE Healthcare, Roche Diagnostics Limited, Siemens AG, Thermo Fisher Scientific Inc.
About Market Research Reports, Inc.
Market Research Reports, Inc. (www.MarketResearchReports.com) is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter
Mr. Amitava Sen
General Manager - Sales & Marketing
Market Research Reports, Inc.
Tel USA: +1-302-703-7787
Tel India: +91-80-26860858
Follow us on LinkedIn : http://www.linkedin.com/company/market-research-reports-inc-
Follow us on twitter: https://twitter.com/MyMarketReports
Follow us on Facebook : http://www.facebook.com/Market.Research.Report
Follow us on YouTube : http://www.youtube.com/user/MarketResearchReport
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to firstname.lastname@example.org)).
(c) 2013 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]